Alterity Therapeutics (ATHE) Total Liabilities (2009 - 2026)

Alterity Therapeutics has reported Total Liabilities for 18 years, with the latest figure at $2.3 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 0.71% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $2.3 million, a 0.71% increase from a year earlier, with the FY2026 full-year figure at $2.3 million, up 166.47% from the prior year.
• Total Liabilities was $2.3 million for Q2 2026 at Alterity Therapeutics, up from $1.7 million in the prior quarter.
• The five-year high for Total Liabilities was $4.2 million in Q2 2022, with the low at $45047.3 in Q2 2023.
• Average Total Liabilities over 5 years is $2.1 million, with a median of $2.3 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities plunged 98.93% in 2023, then soared 4176.82% in 2025.
• Over 5 years, Total Liabilities stood at $3.5 million in 2022, then decreased by 14.24% to $3.0 million in 2023, then plunged by 39.3% to $1.8 million in 2024, then slipped by 3.6% to $1.7 million in 2025, then jumped by 34.27% to $2.3 million in 2026.
• The last three Total Liabilities figures came in at $2.3 million (Q2 2026), $1.7 million (Q4 2025), and $2.3 million (Q2 2025), per Business Quant data.